Table 3 Asthma revolving drug fund expenditure for medicines and other items related to asthma management, Benin 2008–2013
From: Assessment of a revolving drug fund for essential asthma medicines in Benin
Orders | Number of inhalers procured (1) | Purchase price per inhaler (€) (2) | Purchase price, total inhalers (€) (3 = 1*2) | Transport and ADF fees (€) (4) | Total cost (€) (3 + 4) |
|---|---|---|---|---|---|
Beclometasone | |||||
1st order | 1,386 | 1.07 | 1,483 | 2,557 | 4,040 |
2nd order | 3,000 | 0.99 | 2,970 | 1,135 | 4,111 |
3rd order | 3,000 | 0.99 | 2,970 | 2,747 | 5,717 |
(a) Subtotal | 7,386 | 7,423 | 6,438 | 13,867 | |
Salbutamol | |||||
1st order | 681 | 0,83 | 565 | 329 | 894 |
2nd order | 3,114 | 0.83 | 2,585 | 2,585 | |
3rd order | 2,520 | 0.84 | 2,117 | 1,178 | 3,287 |
4th order | 2,550 | 0.83 | 2,117 | 2,149 | 4,254 |
(b) Subtotal | 8,865 | 7,382 | 1,507 | 11,020 | |
(c) Expenditure for procuring inhalers (a + b) | 24,887 | ||||
(d) Other expenditure | 4,338 | ||||
Total expenditure (c + d) | 29,225 |